cytarabine and parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer

cytarabine has been researched along with parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chhabra, J; Kumar, R; Narang, R; Pahwa, R1

Reviews

1 review(s) available for cytarabine and parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer

ArticleYear
Melphalan: Recent insights on synthetic, analytical and medicinal aspects.
    European journal of medicinal chemistry, 2022, Aug-05, Volume: 238

    Topics: Antineoplastic Agents, Alkylating; Drug Resistance, Neoplasm; Humans; Melphalan; Multiple Myeloma; Prodrugs; Structure-Activity Relationship

2022